🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2, double-blind, randomized, multicenter, placebo-controlle...
Status
Completed
Location
Preferred Research Partners, Inc.
Start Date
2022-12-06
Trial ID
NCT05679908
Treatments Being Tested
Oxytocin is neurohypophysial peptide that acts mainly as a neuromodulator i...
Status
Completed
Location
Northwestern University Feinberg School of Medicine
Start Date
2015-04
Trial ID
NCT02550093
Treatments Being Tested
The study aims to investigate whether intranasal oxytocin (OXT) improves se...
Status
Recruiting
Location
University Hospital Basel
Start Date
2025-07-01
Trial ID
NCT06808516
Treatments Being Tested
This is a randomized, double blind, placebo-controlled study of the effects...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2017-07-01
Trial ID
NCT03043053
Treatments Being Tested
The purpose of this research study is to learn about the effects of supplem...
Status
Completed
Location
Lurie Center for Autism, Massachusetts General Hospital
Start Date
2014-08-01
Trial ID
NCT01944046
The specific aim of this study is to test whether oxytocin (OT) boosts the ...
Status
Completed
Location
UNC PEP Lab
Start Date
2013-09
Trial ID
NCT01929161
Treatments Being Tested
Autism is a pervasive developmental disorder characterized by core deficits...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2012-06
Trial ID
NCT01624194
Treatments Being Tested
Oxytocin (OXT) is currently regarded as a crucial neuropeptide in the media...
Status
Unknown
Location
University Hospital Zurich, Division of Psychiatry and Psychotherapy
Start Date
2010-05
Trial ID
NCT01066299
Treatments Being Tested
The purpose of this study is to determine whether oxytocin modulates the pr...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-01
Trial ID
NCT03265899
Growing evidence demonstrates the critical contribution of the neuropeptide...
Status
Unknown
Location
Ullevål Hospital
Start Date
2024-09-18
Trial ID
NCT05934812
Treatments Being Tested